Lab-Designed Peptides Block Dangerous Candida Fungal Biofilms Without Killing Cells | Research

The takeaway

Phage display-derived neutralizing antimicrobial peptides inhibit biofilm formation by three clinically important Candida species without killing the fungi.

3 Candida species neutralized
Biofilm formation inhibited in C. albicans, C. auris, and C. parapsilosis without fungicidal activity

What the researchers found

Phage display-derived neutralizing AMPs (nAMPs) effectively inhibited biofilm formation by C. albicans, C. auris, and C. parapsilosis through modulation of pathogenic behavior rather than cell killing.

Why it matters

Candida auris is a CDC urgent threat. Anti-biofilm peptides that work without killing could provide treatment options that don't drive further antifungal resistance.

How the study worked

Phage display screening for peptides with anti-biofilm activity against three Candida species, evaluating neutralizing (non-killing) antimicrobial mechanisms.

What this study cannot tell us

In vitro biofilm assays — in vivo efficacy not tested. Non-killing approaches may need to be combined with immune support for clinical effectiveness.

How to read the evidence

In vitro proof-of-concept study — demonstrates novel anti-virulence approach but lacks in vivo data.

When this study was published

Published in 2026; addresses the urgent C. auris resistance crisis.

The bigger picture

Anti-virulence approaches that disarm pathogens without killing them represent a paradigm shift in antimicrobial therapy, potentially slowing the resistance crisis.

Questions still open

Can neutralizing peptides be combined with conventional antifungals for enhanced efficacy?
Will pathogens develop resistance to anti-biofilm strategies?

Common questions

What are neutralizing antimicrobial peptides?

Unlike traditional antimicrobials that kill pathogens, neutralizing AMPs disarm them by blocking harmful behaviors like biofilm formation. This approach may reduce the development of drug resistance.

Why is Candida auris dangerous?

C. auris is a drug-resistant fungus that causes severe infections in hospitals, often resisting multiple antifungal drugs. It is classified as an urgent threat by the CDC.

Read the original research

Phage Display-Derived Peptides Have Neutralizing Activities Against Biofilm Formation by Candida albicans, Candidozyma auris and Candida parapsilosis.

Pharmaceuticals (Basel, Switzerland), 19(2)

View on PubMed ↗Publisher’s paper ↗

Citation

Bolotnikov, Grigory; Gruber, Daniel; Walter, Jan-Christoph; Kühnel, Kim; Kemal, Turgay; Rodriguez, Armando; Preising, Nico; Ständker, Ludger; Firacative, Carolina; Spellerberg, Barbara; Stenger, Steffen; Rosenau, Frank; Kissmann, Ann-Kathrin. (2026). Phage Display-Derived Peptides Have Neutralizing Activities Against Biofilm Formation by Candida albicans, Candidozyma auris and Candida parapsilosis.. Pharmaceuticals (Basel, Switzerland), 19(2). https://doi.org/10.3390/ph19020286